Fitxers

726783.pdf (384.25 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2022-12-01

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/195781

Economic Implications of Endometriosis: A Review

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1007/s40273-022-01211-0

Resum

Endometriosis is a chronic inflammatory disease that can have serious physical and emotional consequences for patients in terms of pain, quality of life, and infertility. Despite affecting about 10% of women, the pathophysiology and economic impact of the disease are not fully understood. This study aimed to review and summarize research articles quantifying the direct and indirect costs of endometriosis in the context of current national and international treatment guidelines. A search including the terms 'endometriosis' AND 'costs' OR 'cost of illness' OR 'cost analysis' OR 'economic burden' was performed, focusing on studies published between January 2000 and May 2022. Total costs, costs of primary and secondary care, productivity losses, and indirect costs were reported (...)

Matèries

Política sanitària, Economia de la salut, Endometriosi

Matèries (anglès)

Medical policy, Medical economics, Endometriosis

Citació

Col·leccions

Articles publicats en revistes (Economia)

Citació

DARBÀ, Josep and MARSÀ, Alícia. Economic Implications of Endometriosis: A Review. PharmacoEconomics. 2022. Vol. 40, num. 12, pags. 1143-1158. ISSN 1170-7690. [consulted: 13 of July of 2026]. Available at: https://hdl.handle.net/2445/195781

Exportar metadades

JSON - METS

Compartir registre